Real-time enrollment status for this diabetic retinopathy (dr) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:07 PM UTC
| NCT Number | NCT07222293 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Retinopathy (DR) |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Artelus AI |
| Last Updated on CT.gov | December 9, 2025 (Dec 9, 2025) |
As of July 13, 2026: Clinical trial NCT07222293 is currently recruiting participants. This clinical trial study for diabetic retinopathy (dr) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Artelus AI. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222293 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222293 was last updated Dec 9, 2025 (December 9, 2025). HelloStudys verifies this status automatically.